Donovan Joanne M. (CIK 1644087) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-02). Recent activity: Buy EWTX (28,662 shares), Sell EWTX (28,662 shares), Buy EWTX (21,338 shares), Sell EWTX (21,338 shares), Sell EWTX (9,623 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Buy | 28,662 | $202,927 |
| 2026-04-02 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 28,662 | $926,095 |
| 2026-03-31 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Buy | 21,338 | $151,073 |
| 2026-03-31 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 21,338 | $685,377 |
| 2026-03-30 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 9,623 | $298,121 |
| 2026-03-30 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 6,735 | $208,650 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Buy | 5,781 | $0 |
| 2025-08-14 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 2,862 | $38,322 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Buy | 10,417 | $0 |
| 2025-05-07 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 5,187 | $85,326 |
| 2025-01-30 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Buy | 25,000 | $177,000 |
| 2025-01-30 | Edgewise Therapeutics, Inc. (EWTX) | CMO | Sell | 25,000 | $690,750 |
Source: SEC Form 4 filings · as of 2026-04-02